Williams et al., “Polymers for IUdR Radiosensitization of Experimental Glioblastoma,” Society Neuro Oncoloty Abstract: Post Nov. 1997 Meeting. |
Williams et al., “Implantable Biodegradable Polymers for IUdR Radiosensitization of Human Malignant Glioma In Vivo,” American Radium Society Abstract: Podium Presentation 1996 San Francisco. |
Williams et al., “Implantable Biodegradable Polymers for IUdR Radiosensitization of Human Malignant Glioma In Vivo,” American Society for Clinical Oncology Annual Meeting 1995 Poster Presentation (Abstract). |
Williams et al., “Polymers for IUdR Radiosensitization of Experimental Glioblastoma,” Congress of Neurological Surgeons Abstract: 1997. |
Williams et al. “Implantable Biodegradable Polymers for Radiosensitization of Human Glioma in Vivo,” American Society for Therapeutic Radiation and Oncology: Abstract Annual Meeting 1997. |
Williams et al. “Implantable Biodegradable Polymers for IUdR Radiosensitization of Human Glioma in Vivo,” American Society for Therapeutic Radiation and Oncology: Abstract Annual Meeting 1997. |
Williams et al., “Controlled Release of Radiochemicals from Implantable Biodegradable Polymer Devices,” Society Nuclear Medicine Abstract. |
Van Gool et al., “Overexpression of human poly(ADP-ribose) polymerase in transfected hamster cells leads to increased poly(ADP-ribosyl)ation and cellular sensitization to γ irridation,” Eur. J. Biochem 244:15-20 (1997). |
Williams et al., “Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma,” Journal of Neuro-Oncology 32:181-192 (1997). |
Williams et al. “Combined intracranial iudr polymers and 125-l seets for radiosensitizatio of experimental malignant glioma brachytherapy,” American Society for Therapeutic Radiation and Oncology Abstract Annual Meeting 1997. |
Mao et al., “Biodegradable Copolymer for Drug Delivery: Poly(phosphate-terephthalate)s,” Proceedings of the Topical Conference on Biomaterials Carriers for Drug Delivery and Scaffold for Tissue Engineering, Peppas, N.A., et al. eds. Los Angeles, CA, pp. 141-143 (1997). |
Mao et al., “Design of New Biodegradable Polymers Based on Chain-Extension of Oligomeric Lactides by Phosphates,” Proceedings of the Topical Conference on Biomaterials Carriers for Drug Delivery and Scaffold for Tissue Engineering, Peppas, N.A., et al., eds. Los Angeles, CA, pp. 193-195 (1997). |
Pretula et al., “High-molecular-weight poly(alkylene phosphonate)s by condensation of dialkylphosphonates with diols,” Die Makromolekulare Chemis 191:671-680 (1990). |
Bruin et al., “Biodegradable Lysine Diisocyanate-based Poly(glycolide- co-ε- caprolactone)—urethane Network in Artificial Skin”, Biomaterials, 11 (4): 291-295 (1990). |
Chien, Y. W. et al., Novel Drug Delivery Systems (1982). |
Choueka et al., “Canine Bone Response to Tyrosine- derived Polycarbonates and Poly( L- lactic Acid)”, Journal of Biomedical Materials Research, 31 : 35-41 (1996). |
Ertel et al., “Evaluation of Poly( DTH Carbonate), a Tyrosine- derived Degradable Polymer, for Orthopedic Applications”, Journal of Biomedical and Materials Research, 29: 1337-1348 (1995). |
Kadiyala et al., “Poly ( phosphoesters): Synthesis, Physico- chemical Characterization and Biological Response”, Biomedical Applications of Synthesic Biodegradable Polymers, Chpt. 3, 33-55 (Hollinger ed. 1995). |
Langer et al., “Controlled Release of Bioactive Agents”, Rev. Macro. Chem. Phys., C23 (1), 61-125 (1983). |
Langer et al., “New Methods of Drug Delivery”, Science, 249 (4976): 1527-1533 (1990). |
Leong et al., “Polyanhydrides for Controlled Release of Bioactive Agents”, Biomaterial:364 (1986). |
Leong et al., “Polymeric Controlled Drug Delivery”, Advanced Drug Delivery Reviews, 1, :199-233 (1987). |
Penczek et al., “Phosphorus- Containing Polymers”, Handbook of Polymer Synthesis, Part B, Chpt 17, pp. 1077-1132 (Kricheldorf ed. 1992). |
Pulapura et al., “Trends in the Development of Bioresorbable Polymers for Medical Applications”, Journal of Biomaterials Applications, 6 (1) :216-250 (1992). |